Chon etal.[29] demonstrated that the OV mJX‐594was able to sensitize ICI‐resistant tumours and promote significant T‐cell infiltration into tumours in mice, and, in combination with anti‐PD‐1 therapy, reduced tumour growth by a 70%. Here, PDCD1 is linked to neoplasm.